000 01566 a2200457 4500
005 20250511205604.0
264 0 _c19910606
008 199106s 0 0 eng d
022 _a0895-7061
024 7 _a10.1093/ajh/4.2.128s
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGómez, G
245 0 0 _aMulticenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population.
_h[electronic resource]
260 _bAmerican journal of hypertension
_cFeb 1991
300 _a128S-130S p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntihypertensive Agents
_xadverse effects
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aBody Weight
_xdrug effects
650 0 4 _aCohort Studies
650 0 4 _aColombia
_xepidemiology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aIsradipine
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscle, Smooth, Vascular
_xdrug effects
650 0 4 _aPyridines
_xadverse effects
700 1 _aMelgarejo, E
700 1 _aNarváez, J
700 1 _aGamarra, G
700 1 _aRestrepo, G
700 1 _aAcevedo, L
700 1 _aIzurieta, A
773 0 _tAmerican journal of hypertension
_gvol. 4
_gno. 2 Pt 2
_gp. 128S-130S
856 4 0 _uhttps://doi.org/10.1093/ajh/4.2.128s
_zAvailable from publisher's website
999 _c1833209
_d1833209